A new and intriguing discovery is raising hope in the world of cancer research: A common nutritional component found in everyday vegetables may improve the body’s ability to fight tumors and even strengthen advanced treatments.
The study, conducted at the University of Chicago Medical Center and published in the journal Cell Reports Medicine, found that zeaxanthin – a natural substance mainly known for supporting eye health – may also play an important role in the fight against cancer.
The researchers discovered that zeaxanthin strengthens CD8+ T immune cells – key cells in identifying and destroying cancer cells. The substance helps stabilize a key mechanism in these cells, leading to stronger activation, increased production of anti-inflammatory substances, and an improved ability to eliminate tumors.
In animal experiments, adding zeaxanthin to the diet slowed the rate of tumor growth. When combined with immunotherapy treatments – among the most advanced cancer treatments today – the effect was even more significant.
In laboratory experiments on human cells, zeaxanthin also improved the ability of immune system cells to destroy various types of cancer, including melanoma, multiple myeloma, and brain tumors.
One of the prominent advantages of zeaxanthin is its accessibility:
The implication is the potential for a relatively simple solution that can be integrated into existing treatments.
Despite the encouraging results, the researchers emphasize that this is an early stage. Most of the findings are based on laboratory and animal experiments, and clinical trials in humans are required to determine whether the effect will indeed translate into improved treatment for patients.
The study opens a new field called “nutritional immunology” – which examines how components from food affect the immune system at the molecular level.
If the findings are confirmed in future studies, it is possible that in the future, diet or simple supplements will become an integral part of cancer treatment – and help make it more effective and accessible.
Source:
www.jpost.com
